Oxford/AstraZeneca COVID-19 Vaccine Most Popular Worldwide

Consumer Services & Health

Lite

Andrea Lidwina 04/12/2020 14:59 WIB

URL has been copied

Memuat...

The Oxford/AstraZeneca COVID-19 vaccine is currently undergoing Phase III clinical trials, but 2.5 billion doses have already been pre-ordered by several countries.

Number of Purchased Doses of COVID-19 Vaccines Still Undergoing Phase III Clinical Trials (as of November 30, 2020)

A Font Kecil
A Font Sedang
A Font Besar

Access single data

Oxford/AstraZeneca COVID-19 Vaccine Most Popular Worldwide

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Number of Purchased Doses of COVID-19 Vaccines Still Undergoing Phase III Clinical Trials (as of November 30, 2020)

Download

Source

A Small Font
A Medium Font
A Bigger Font

The Oxford/AstraZeneca Covid-19 vaccine is currently undergoing Phase III clinical trials, but 2.5 billion doses have already been ordered by several countries. This is the largest number among other vaccine candidates in the same trial phase.

Furthermore, 1.3 billion doses of the Novavax vaccine have been secured by six countries. BioNTech/Pfizer has secured 645.9 million doses, Moderna 377.5 million doses, Janssen 370 million doses, Gamaleya 304 million doses, and Sinovac 176.1 million doses.

Meanwhile, the number of purchased doses for the Medicago, Sinopharm/G42, and CanSino coronavirus vaccines is less than 100 million doses.

Editor : Muhammad Ahsan Ridhoi

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."